High-Risk Drug Monitoring Service · London

High-Risk Drug Monitoring Service in London.

Systematic monitoring of high-risk medicines across the practice list — DMARDs, lithium, amiodarone, anticoagulants, valproate — with pharmacist-led recall and prescribing safety reporting. Delivered to London PCNs and GP practices from the BCS Chiswick (West London) hub, with paired cover from our Halifax (West Yorkshire) hub — the only UK dual-hub clinical pharmacy model.

London · local context

London PCNs sit within five London ICBs (NW, NC, NE, SE, SW London).

London PCNs operate across five ICB footprints with the country's most diverse patient cohorts and the highest care home density per square mile — pharmacist programmes here have to flex from inner-city deprivation in Tower Hamlets to commuter-belt frailty in Bromley.

For high-risk drug monitoring specifically, the London pathway typically integrates with Imperial, UCLH, Barts Health, King's and St George's. BCS standardises the cross-organisation workflow into a single hub-supervised process.

What you get

What high-risk drug monitoring in London actually looks like.

  • Quarterly DMARD bloods recall and recording
  • Anticoagulant INR / DOAC reviews
  • Lithium and amiodarone monitoring cycles
  • Valproate Pregnancy Prevention Programme oversight
  • Safety alert action and audit evidence

Dual-hub delivery

The only UK provider with a Yorkshire + London hub.

Every high-risk drug monitoring placement in London is mobilised from one of our two clinical hubs — Chiswick (West London) as the lead and Halifax (West Yorkshire) as paired cover. The dual-hub model is unique to BCS: same SOPs, same supervision, same-week cross-cover.

  • Lead delivery from the BCS Chiswick (West London) hub
  • Paired cover from BCS Halifax (West Yorkshire)
  • Same-week sickness, leave and maternity cover
  • ARRS-compliant, GPhC-registered workforce
  • One SLA, one report, one escalation point

London · what good looks like

Typical first-year markers.

4–6 wks
Mobilisation in London
2 hubs
Halifax + Chiswick — unique to BCS
100%
Supervision evidenced for audit
Monthly
QA-checked outcomes report

Why London PCNs choose BCS for high-risk drug monitoring.

Solo recruitment for high-risk drug monitoring in London leaves a network exposed to sickness, maternity and retention risk, and rarely meets the supervision standard ICBs now ask for. BCS removes all of that — pharmacists are part of a clinical team, supervision is built in, and continuity is guaranteed by the Chiswick (West London)/Halifax (West Yorkshire) dual-hub.

Frequently asked questions — High-Risk Drug Monitoring Service in London.

Does BCS handle MHRA safety alert response?+

Yes — every active MHRA alert is mapped to a BCS pharmacist workflow with action evidence per practice.

Does BCS already deliver high-risk drug monitoring in London?+

BCS supports PCNs across London from our Chiswick (West London) hub with paired cover from Halifax (West Yorkshire), and is actively delivering or available to mobilise high-risk drug monitoring in London. Get in touch and we'll confirm current capacity.

How quickly can BCS mobilise high-risk drug monitoring in London?+

In most cases inside 4–6 weeks of contract sign-off, with HSCN-secured remote prescribing back-up available sooner where capacity is urgent.

Talk to our Service Development team

30-minute discovery call. We'll show you how BCS maps to your PCN's specific priorities.

Book a discovery call